home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

In utero Protein Regulation

  February, 22 2007 9:36
your information resource in human molecular genetics
A novel strategy for regulating a protein important in development is described in Nature this week. Michael T. Longaker and colleagues report that, in mice, glycogen synthase kinase-3beta (GSK-3beta) can be artificially controlled from within the mother's uterus, in a reversible and time-controlled manner.

GSK-3beta plays an integral part in a variety of biological processes, although its specific developmental roles remain unclear. In the present study the authors used an existing chemically regulated form of the GSK-3beta gene, whereby expression of the GSK-3beta protein is controlled by the presence or absence of the drug rapamycin. Using this approach combined with conventional mutant analysis they defined a specific requirement for GSK-3beta in midline development: mice that did not express the protein had cleft palate, incomplete fusion of the ribs and a split sternum.

In addition, the authors were able to rescue some of the developmental defects using maternal rapamycin treatment to restore internal GSK-3beta activity during two distinct windows of gestation. They propose that their studies provide an improved method for defining the timing and level of protein expression during development, a detailed knowledge of which is essential for rescuing developmental defects.

Author contact:

Michael T. Longaker (Stanford University Medical Center, CA, USA)
E-mail: longaker@stanford.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.